Matas A/S
SWB:1MTA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Matas A/S
SWB:1MTA
|
DK |
|
B
|
Biomarin Pharmaceutical Inc
F:BM8
|
US |
Wall St Price Targets
1MTA Price Targets Summary
Matas A/S
According to Wall Street analysts, the average 1-year price target for 1MTA is 18.72 EUR with a low forecast of 16.18 EUR and a high forecast of 21.72 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1MTA's stock price target?
Price Target
18.72
EUR
According to Wall Street analysts, the average 1-year price target for 1MTA is 18.72 EUR with a low forecast of 16.18 EUR and a high forecast of 21.72 EUR.
What is the Revenue forecast for Matas A/S?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 7 years is 4%.
What is the Gross Profit forecast for Matas A/S?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 4 years is 6%.
What is the Operating Income forecast for Matas A/S?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 7 years is 8%.
What is the Pre-Tax Income forecast for Matas A/S?
Projected CAGR
23%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 23%.
What is the Net Income forecast for Matas A/S?
Projected CAGR
29%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 29%.
